However, it appears less variable across NET subgroups than other single biomarkers, such as chromogranin A. Visfatin/NAMPT plays an important role in cancer biology—in cell migration, tissue proliferation, and metabolic regulation—making it an attractive candidate both in biomarker research and as a therapeutic target. The gene discussed is CHGA; the disease is cancer.